A Phase II Study of Sunitinib in Patients With Refractory or Relapsed Germ Cell Tumors.
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 26 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2009 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.
- 12 Apr 2007 Status changed from initiated